Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China. (Q52759733)

7 May 2018

title

Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China. (English)

1 reference

7 May 2018

1 reference

Y Tan

1

1 reference

7 May 2018

Z Q Luan

2

1 reference

7 May 2018

J B Hao

3

1 reference

7 May 2018

D Song

4

1 reference

7 May 2018

F Yu

5

1 reference

7 May 2018

M H Zhao

6

1 reference

7 May 2018

publication date

1 January 2017

1 reference

7 May 2018

published in

Lupus

1 reference

7 May 2018

page(s)

961203317723715

1 reference

7 May 2018

Evaluation of clinical outcomes and renal vascular pathology among patients with lupus

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Systemic antithrombotic effects of ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Noninflammatory necrotizing vasculopathy in lupus nephritis: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

The interaction between factor H and Von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Complement activation in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

The spectrum of renal thrombotic microangiopathy in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203317723715

21 January 2018

Identifiers

DOI

10.1177/0961203317723715

1 reference

7 May 2018

1 reference

7 May 2018